July 10, 2013

UCB Inc. et al v. Accord Healthcare Inc. et al

View recent docket activity


Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.


Coverage

  1. August 16, 2016

    UCB's Anti-Convulsant Patent Is Valid, Delaware Judge Rules

    A UCB Inc. patent for the anti-convulsant Vimpat is valid, a Delaware federal judge said in an opinion unsealed on Monday, blocking attempts by Actavis Inc., Mylan Pharmaceuticals Inc., Apotex Inc.. and several other drugmakers to make and sell a generic versison of the drug.

1 other articles on this case. View all »

Parties

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Direct access to case information and documents.
  • All significant new filings across U.S. federal district courts, updated hourly on business days.
  • Full-text searches on all patent complaints in federal courts.
  • No-fee downloads of the complaints and so much more!

TRY LAW360 FREE FOR SEVEN DAYS